Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
May 3, 2018
Celyad Successfully Administers CYAD-01 in First Patients in SHRINK and LINK Trials
MONT-SAINT-GUIBERT, Belgium, May 03, 2018 (GLOBE NEWSWIRE) -- Celyad (Euronext Brussels:CYAD) (CYAD) (CYAD) a clinical-stage biopharmaceutical company focused on the development of CAR-T cell therapies, ...
May 3, 2018
World Health Organization Grants Name ‘Seliforant’ to Sensorion’s SENS-111 Treatment
MONTPELLIER, France, May 03, 2018 (GLOBE NEWSWIRE) -- Sensorion (FR0012596468 – ALSEN), a biotech company specializing in the treatment of inner ear diseases, today announces ...
May 3, 2018
Minerva Neurosciences Reports First Quarter 2018 Financial Results and Business Updates
WALTHAM, Mass., May 03, 2018 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central ...
May 3, 2018
Catalyst Biosciences Reports First Quarter Operating & Financial Results and Provides Corporate Update
SOUTH SAN FRANCISCO, Calif., May 03, 2018 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (CBIO), today announced operating and financial results for the first quarter ending ...
May 3, 2018
BioLife Solutions to Report First Quarter 2018 Financial Results and Provide Business Update on May 10, 2018
BOTHELL, Wash., May 3, 2018 /PRNewswire/ -- BioLife Solutions, Inc. (BLFS), the leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze ...
May 3, 2018
Opiant Pharmaceuticals To Host Key Opinion Leader Meeting on Medications for Addictions and Related Disorders
SANTA MONICA, Calif., May 03, 2018 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. ("Opiant") (OPNT), a specialty pharmaceutical company developing pharmacological treatments for addictions, will host ...
May 3, 2018
BioDelivery Sciences Confirms Receipt of Notice of Intent to Nominate Directors by Broadfin Capital
RALEIGH, N.C., May 03, 2018 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (BDSI) today issued the following statement with respect to its receipt of a ...
May 3, 2018
Vermillion to Report First Quarter 2018 Financial Results on Monday, May 14
AUSTIN, Texas, May 03, 2018 (GLOBE NEWSWIRE) -- Vermillion, Inc. (VRML), a bio-analytical solutions company focused on gynecologic disease, announced today that it will report ...
May 3, 2018
Gemphire Therapeutics Announces the Appointment of Steven Gullans, Ph.D., as President and Chief Executive Officer
LIVONIA, Mich., May 03, 2018 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (GEMP), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for cardiometabolic disorders, ...
May 3, 2018
TherapeuticsMD Announces First Quarter 2018 Financial Results
BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (TXMD), an innovative women’s healthcare company, today announced its financial results for the quarter ended March 31, 2018. ...
May 1, 2018
BioTime Presents Updated OpRegen® Clinical Trial Data at ARVO
ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE American: BTX), a clinical-stage biotechnology company focused on degenerative diseases, today announced that an abstract related to one of its ...
May 1, 2018
Arena Pharmaceuticals and Outpost Medicine Enter into Licensing Agreement for Undisclosed Novel Compound
SAN DIEGO and INDIANAPOLIS, May 1, 2018 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (ARNA), a biopharmaceutical company focused on developing novel, small molecule drugs across multiple therapeutic ...
May 1, 2018
BrainStorm Cell Therapeutics to Participate in Movement Disorder Panel at the Neurotech Investing and Partnering Conference
NEW YORK and PETACH TIKVAH, Israel, May 1, 2018 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (BCLI), a leading developer of adult stem cell therapies for neurodegenerative ...
May 1, 2018
AzurRx BioPharma Announces Pricing of $10.4 Million Public Offering of Common Stock
BROOKLYN, N.Y., May 01, 2018 (GLOBE NEWSWIRE) -- AzurRx BioPharma (AZRX), (“AzurRx” or the “Company”), today announced the pricing of an underwritten public offering of ...
May 1, 2018
Paratek Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
BOSTON, May 01, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon ...
May 1, 2018
Pernix Therapeutics to Report First Quarter 2018 Financial Results on Thursday, May 10
MORRISTOWN, N.J., May 01, 2018 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (PTX), a specialty pharmaceutical company, announced today that the Company will report financial ...
May 1, 2018
Theravance Biopharma to Report First Quarter 2018 Financial Results on May 8, 2018
DUBLIN, May 1, 2018 /PRNewswire/ -- Theravance Biopharma, Inc. (TBPH) ("Theravance Biopharma" or the "Company") today announced that it will release financial results for the ...
May 1, 2018
Prothena to Report First Quarter 2018 Financial Results on May 8
DUBLIN, Ireland, May 01, 2018 (GLOBE NEWSWIRE) -- Prothena Corporation plc (PRTA), a clinical-stage biotechnology company focused on the discovery and development of novel therapies ...
May 1, 2018
TherapeuticsMD to Host First Quarter Financial Results Conference Call and Webcast on May 3
BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (TXMD), an innovative women’s healthcare company, today announced that it will host a conference call and live audio webcast to ...
May 1, 2018
Zogenix Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
EMERYVILLE, Calif., May 01, 2018 (GLOBE NEWSWIRE) -- Zogenix, Inc. (ZGNX), a pharmaceutical company developing therapies for the treatment of rare central nervous system (CNS) ...
Page 45 of 117